SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-020794
Filing Date
2021-02-11
Accepted
2021-02-11 17:07:15
Documents
59
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm215685d1_10q.htm 10-Q 384026
2 EXHIBIT 10.2 tm215685d1_ex10-2.htm EX-10.2 30811
3 EXHIBIT 31.1 tm215685d1_ex31-1.htm EX-31.1 10248
4 EXHIBIT 31.2 tm215685d1_ex31-2.htm EX-31.2 10274
5 EXHIBIT 32.1 tm215685d1_ex32-1.htm EX-32.1 6849
  Complete submission text file 0001104659-21-020794.txt   3525926

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nbse-20201231.xml EX-101.INS 854975
7 XBRL TAXONOMY EXTENSION SCHEMA nbse-20201231.xsd EX-101.SCH 29641
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbse-20201231_cal.xml EX-101.CAL 34350
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbse-20201231_def.xml EX-101.DEF 71600
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbse-20201231_lab.xml EX-101.LAB 306411
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbse-20201231_pre.xml EX-101.PRE 211409
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35963 | Film No.: 21620783
SIC: 2834 Pharmaceutical Preparations